Lessons Learned From Enhancing Vaccine Pharmacovigilance Activities During PsA-TT Introduction in African Countries, 2010–2013
Fabien Diomandé(Unknown), Patrick Zuber(World Health Organization), Samba O. Sow(Centre Pour le Développement des Vaccins-Mali), Kirsten Vannice(Gates Foundation), Claude-Roger Ouandaogo(Direction Générale de la Pharmacie, du Médicament et des Laboratoires), Modibo Keita(Centre Pour le Développement des Vaccins-Mali), Simonetta Viviani, Tènè Marceline Yaméogo(Nazi Boni University), Marie‐Pierre Préziosi(World Health Organization), Bartholomew D. Akanmori(World Health Organization Regional Office for Africa), Mamoudou Harouna Djingarey, N Mbakuliyemo
Cited by 19
Related Papers
Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses
|The Lancet|2022|407
Low plasma concentrations of interleukin 10 in severe malarial anaemia compared with cerebral and uncomplicated malaria
|The Lancet|1998|329
Plasma Antibodies from Malaria-Exposed Pregnant Women Recognize Variant Surface Antigens on <i>Plasmodium falciparum</i> -Infected Erythrocytes in a Parity-Dependent Manner and Block Parasite Adhesion to Chondroitin Sulfate A
|The Journal of Immunology|2000|305
Absolute Levels and Ratios of Proinflammatory and Anti‐inflammatory Cytokine Production In Vitro Predict Clinical Immunity to<i>Plasmodium falciparum</i>Malaria
|The Journal of Infectious Diseases|2002|245